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Hypocalcemic cardiomyopathy in infants is characterized by heart failure in a previously normal infant with
hypocalcemia without organic cardiac lesion. Vitamin D deficiency rickets is increasing in Middle East. In a six month
study 136 cases of rickets were diagnosed in the main Children’s Hospital in Almadinah but none of them showed
evidence of cardiomyopathy. Concerned of missing this serious complication of rickets we searched pub med and
present this review article.
Results: 61 cases of hypocalcemic cardiomyopathy were reported as case reports with two series of 16 and 15 cases
from London and Delhi, respectively. The major features of these cases: the age ranged from one month to 15 months
with a mean age of 5 months. All presented with heart failure and hypocalcemia. There was a minor feature of rick-
ets in a few of the cases. All had high alkaline phosphatase. Echocardiology evidence of cardiomyopathy was found
in all. Most of them responded to calcium, vitamin D and cardiotonic and diuretics.
Discussion: We concentrated on pathogenesis of this hypocalcemic cardiomyopathy and reviewed the literature.
The evidence available supports that the most likely cause of cardiomyopathy is hypocalcemia. Hypovitamin D also
contributes but hyperparathyroidism might have a protective role as we did not detect any evidence of cardiomyop-
athy with hyperparathyroidism and florid features of rickets.
Conclusion: We need to look out for cardiomyopathy among infants with hypocalcemia. For prevention maternal
supplementation during pregnancy and lactation with up to 2000 units of vitamin D and 400 units for their infants.
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Cardiomyopathy in infants is characterized byheart failure in apparently normal children
without previous organic cardiac lesions. The
Pediatric Cardiomyopathy Registry of USA con-
tains clinical and causal information for 916 North
American children who were diagnosed as having
cardiomyopathy. Cardiomyopathy has been
found to comprise four types with different inci-
dence rates; hypertrophic (34.2%), dilated
(53.8%), restrictive (3.2%), and other or mixed
(8.9%). Only one third of the cases had a known
cause. Children with a known cause for hypertro-
phic cardiomyopathy included more females than
males in relatively younger age groups, present-
ing with congestive heart failure, and increased
left ventricular posterior wall thickness without
outflow tract obstruction. For dilated cardiomyop-
athy (DCM), a known cause was associated with
older age, lower heart rate, smaller left ventricular
dimensions, and greater shortening fraction [1]. In
all these cases there was no mention of hypocalce-
mia as one of the causative factors. In Pakistan, a
developing country, the relative incidence of
DCM was reported to be 9%, in patients with a
mean age of 5 years and none of them were hypo-
calcemic [2]. The association of heart failure and
hypocalcemia was first reported in 1949 by Dodd
and Rapport who stated that cardiac manifesta-
tions could be linked to hypocalcemia though in
the presence of other electrolyte deficiency [3].
In 1955, Schulman and Ratner reported a 12 years
old girl with chronic hypoparathyroidism and car-
diac failure that improved with a correction of cal-
cium [4]. In 1963 [5] Edge reported congestive
heart failure associated with hypocalcemia in in-
fancy. The first case of frank rickets presenting
with heart failure occurring in an 18 months old
infant was reported by Najjar, in 1967 [6]. Trough-
ton and Singh in 1972 [7] reported six neonates
with hypocalcemia and heart failure. The fact that
heart function returned to normal as soon as these
patients were subjected to calcium regiment, was
a clear proof of that low serum calcium was the di-
rect cause of DCM in these individuals. The term
hypocalcemic cardiomyopathy was coined by Bas-
hour et al. in1980 while reporting the cases of a
10 years old girl and a 36 years-old woman, both
presenting with hypocalcemia and heart failure,
and showing a dramatic response to calcium
therapy [8]. Gillor et al in 1989 were the first to
report that heart failure in a three and a half
months old rickets patient is caused by vitamin
D deficiency [9]. This patient responded promptly
to adequate calcium therapy accompanied byusual anti-congestive therapy. Since vitamin D
deficiency-induced rickets is common in Middle
East with hypocalcemia being the most common
manifestation during the first year of life among
breastfed infants, in this review we will discuss
the recent literature on hypocalcemic rachitic car-
diomyopathy [10–12]. We will highlight the latest
advances in diagnosing and treating this disease,
with particular emphasis on the latest advances
in the Middle East.Methods
We searched Pub Med using the key words
hypocalcemia, rickets and dilated cardiomyopathy
in children. Also, we reviewed cases with a diag-
nosis of cardiomyopathy admitted to Peditric
Intensive Care Unit (PICU) of Medinah Maternity
and Childrens Hospital (MMCH) retrospectively
in a period of one year.
As part of the study of rickets in MMCH studied
cases seen in outpatient with features of rickets
were examined by echocardiography to detect
any abnormality suggestive of cardiomyopathy
in a period of six months from September 2008
to March 2009.Results
The Pub Med review for hypocalcemia and car-
diomyopathy revealed 23 publications including
59 case reports of infants (see Table 1), as well as
16 cases reported from the London region [13]
and fifteen from Delhi [14]. Also 5 cases reported
from Delhi in which hypocalcemia and cardiomy-
opathy were not only presenting features, but also
cardiogenic shock [15]. Additionally, we noted
four cases from one center in USA as well as re-
ports of two cases in each from UAE, UK and
France. The remaining were single case reports
from different parts of the world.
Interestingly, a one-year survey of cases at the
pediatric intensive care unit (PICU), Al-Madinah
Maternity and Children Hospital (MMCH), King-
dom of Saudi Arabia did not reveal any cardiomy-
opathy that is associated with hypocalcemia. This
observation is consistent with our survey con-
ducted by us in the outpatient unit of the same
hospital. As a part of our study on rickets to be re-
ported, these 35 outpatient cases with frank rickets
that were examined using echocardiography
(echo) and did not reveal any cardiac defect sug-
gestive of cardiomyopathy.
To summarize this literature review, that of Mai-
ya et al. [13] reported 16 cases of hypocalcaemia
REVIEW ARTICLE
Table 1. Clinical, biochemical and cardiological features in infants with dilated cardiomyopathy, hypocalcemia and rickets.
Reference yr S(No) Age(Gen) Fed on Origin Present Diagnosis Cardiac Diagnosis Ca Ph V D AlPIU PTHpg Treatment Out come
Bashour 1980 (7) 10y Nor Serya Tetany HypoPTH CF L H L H L Ca VD RCT G
Gillor1989 (12) 3.5(m) Bf Germa CHF Rickets DCM L L L H H Ca vitdCt G
Yaseen 1993 (17) Infant Bf France CHF Rickets DCM L L L H H Ca vi DCT G
Memmi 1993(18) 1.5(m) Bf France Dysp Ricketsm DCM 1.4 N L H 10 Ca vitdCT G
Karademir1993 (19) 1 m(m) Bf Turky CHF con HypoCa HF L L L H H Ca vitDCT G
Brunvard 1995 (20) 3.5 (f) Bf Norwa CHF Rickets DCM L H L H H Cqa vitDCT G
Lachassinne1992(21) 8 m(ng) Bf France CHF HypoCa HF,EBV L L L H H Ca vitDCT G
Abdulla1999(22) 5 m (m) Bf Canada CHF Rickets DCM L L L H H Ca vitDCT G
Oglun 2003(23) 9 m(F) bf Turky SB Rickets DCM L L L H H Ca VitDCT G
Gulati 2001(24) 4 m(m) Bf India SB VDDR pQoTc L N L H H Cacalcitrol G
Price 2003(25) 5 m Bf USA HF irr Rickets DCM L L L H H Ca D digCT G
C-Conway1004(26)2cases 4.5(f)8(m) Bf UK RD HF Rickets DCM 1.3 L LL H H Ca VitDRCT G
Goulet 2006(27) 2 cases 1 m Bf France Hf hf 22q11 del DCM LL LL LL HH HH Ca viit dCT G
Cramm 2006(28) 3.5 m Bf USA CHF Rickets DCM L L L H H Ca VitDCT G
Roy 2006 (29) Infant Bf UK DCM Adibic aciduria DCM L L L H Diet Diet,Ca G
Amirlak 2008(30) 2cases 9 m  2 Bf UAE CHF Rickets DCM L L L H H Ca vit DCT G
Brown 2009(31)4cases 8 m(fmmm) Bf USA RDC Rickets HF,DCM L L L H, H CaVITDCT G
Kim 2010 (32) 2 m (f) Bf Koria CHF Rickets DCM 5 m 2.3 63 15 Ca vit D CT G
Verma20 11(33) 15 m(m) Bf India CHF Rickets DCM L L L H H Ca vD CT G
Maiya etal 2008 (13)16cases 185.3(mf Bf UK HF Rickets FS 10% L L L H H CavitdCT 3died
Tomar 2010(14) 15cases Infants Bf India HF HypoCa SLVD L L L H H Ca Vit D allGR
Gupta 2011 (15)5 cases 4.7 Bf+_ India CS Rickets DCM L L L H H CavitDdCT 1died
Kumar2011(16) 2 m Bf India CHF No R DCM L L L H H Ca vit D I died
Total 59 5m BF World CHF Rickets FS10–25 L L L H H Mortlity 8.5%
Abbreviations: Af Am, Afirican American; m, male; f, female; yr, year; DCM, dilated cardiomyopathy; L, low; H, high; gen, gender; RD, respiratory distress; Ca, calcium; ALK, alkaline phosphatase; PTH,
parathormone; G, good; EBV EBvirus; ng, not given; HF, heart failure; bf, breast feeding; CT, cardiac treatment; m, month; (m), male; (f), female; hypoCa, hypocalcemia; GR, recovery; CS cardiogenic shock;
VD, vitamin D.
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six years period as shown in Table 1. Ten were
of black ethnicity and six were Indian. Their ages
varied between 3 weeks and 8 months with a med-
ian age of 5.3 months. All had been breastfed.
Median shortening fraction was 10% (range 5–
18%) and median left ventricular end diastolic
dimension z score was 4.1 (range 3.1–7.0). While
six had a periodic cardiac arrest, three infants
died. Eight were ventilated, two required mechan-
ical circulatory support and 12 required intrave-
nous inotropic support. Two were referred for
cardiac transplantation. The average of biochemi-
cal markers on admission were: total calcium 1.5
(1.07–1.74) mmol/l; alkaline phosphatase 646
(340–1057) IU/l; 25-hydroxyvitamin D 18.5 (0–46)
nmol/l (normal range >35) and parathyroid hor-
mone 34.3 (8.9–102) pmol/l (normal range <6.1).
The clinical markers and echocardiographic indi-
ces of all survivors improved upon calcium and
vitamin D regimen. The time from diagnosis to
achieve normal fractional shortening was
12.4 months [13]. Based on these observations
the authors of this study concluded that vitamin
D deficiency and consequent hypocalcaemia were
seen in association with severe and life-threaten-
ing infant heart failure. In addition, the fact that
no infant or mother was receiving the recom-
mended vitamin supplementation highlights the
need for adequate provision of vitamin D to ethnic
minority populations in UK.
Tomar et al. from India [14] reported 15 infants
with age ranging from 45 days to 5 months (med-
ian 2 m) among which 12 presented heart failure
and the remaining 3 cardiogenic shock. While all
these patients had cardiomegaly and seven of
them underwent convulsions episodes, no clinical
signs of rickets were found. Electrocardiogram
(ECG) analysis showed sinus tachycardia and pro-
longed QT interval. While calcium and phospho-
rus levels in the serum were low, the levels of
alkaline phosphatase and parathyroid hormone
(PTH) were high in all the cases described above,
except for one where a significant decrease in the
level of PTH was found. Hemoglobin ranged from
8 to 10 g/dl. Echo revealed dilated left ventricle
and decreased left ventricular ejection fraction.
All received decongestive therapy, calcium and
vitamin D (600,000 IU IM) and magnesium sulfate.
Serum calcium was normalized in all in 2-to-
4 days. One infant had recurrent hypocalcaemia
with tonic spasm leading to aspiration and death.
Ten children received packed cell transfusion.
Fourteen infants were discharged after normaliza-
tion of their calcium levels and QTc interval andtheir LVEF normalized in 12 weeks. Five cases pre-
sented with cardiogenic shock [15]. The details of
the other case reports are shown in the Table 1,
showing similar features of all of them including
the four cases from one institute in USA [16–33].Discussion
The survey of available literature showed that
all the cases presented from a wide range of coun-
tries were among dark skinned breastfed infants
with an age ranging from 1 to 15 months with a
mean age of 5 months. The main conclusion from
all these studies is that this early onset of hypocal-
cemia with such life threatening cardiomyopathy
is most likely due to maternal vitamin D defi-
ciency which was hypothesized by us in 1980
and, as described was later confirmed by subse-
quent reports [34–36]. In addition, heart failure
respiratory distress were noticed in all. Although
all were hypocalcemic and presented a hyperac-
tive parathyroid not all of them developed convul-
sions. Clinical features of rickets were not obvious
in all these cases except in some of them which is
consistent with the early biochemical phase of
rickets. The dramatic response to treatment with
cardiac supporting medications in addition to cal-
cium and vitamin D supplementation was an indi-
cation of a role of vitamin D deficiency and
hypocalcemia in the pathophysiology of these pa-
tients. Cardiomyopathy was diagnosed by clinical
evidence of heart failure with hepatomegaly, car-
diomegaly and low LV ejection fraction (EF%)
<60% as indicated by echo analysis.
Since dilated cardiomyopathy is a life threaten-
ing syndrome, specifically for hypocalcemic in-
fants, and is spreading in an epidemic form in
many countries, in age group below six months
in the majority of cases, we will discuss the differ-
ent factors involved in its pathogenesis. The fact
that in the majority of the cases reported so far;
this syndrome is associated with biochemical fea-
tures of rickets, namely hypocalcemia, hyperpara-
thyroidism and hypovitaminosis D and high
alkaline phosphtase, each one of the three abnor-
malities will be discussed in more details in the
subsequent sections.
The role of hypocalcemia in cardiomyopathy
The importance of normal calcium in controlling
activation of several cellular enzyme cascades and
smooth muscle and myocardial contraction is well
recognized. As described above, the main causes
of hypocalcemia in infants include low vitamin D
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HYPOCALCEMIC RACHITIC CARDIOMYOPATHY IN INFANTSleading to biochemical abnormalities that result in
the development of frank rickets. Numerous stud-
ies, some of which have been discussed above,
have indicated that during the onset of hypocalce-
mia heart muscle is affected giving rise to cardio-
myopathy. In one of the earliest reports on this
association, Troughton and Singh [7] studied 6
cases of neonates and concluded that calcium de-
fect could lead to the development of cardiomyop-
athy in four ways: First, that the low serum
calcium level itself was responsible for the cardiac
manifestations. Second, that a decrease in calcium
level provided the last straw to a myocardium that
had been injured by a previous factor. Third, that
the heart failure was caused by other factors of
which the hypocalcemia was a by-product. Fourth,
that the hypocalcemia was secondary to the heart
failure. The fact that hypocalcemia was associated
with all the cases reported favors the possibility
that the low serum calcium level itself was respon-
sible for the cardiac manifestations. This is sup-
ported by its occurrence within the first months
of life during which hypocalcemia was found in
70% of patients with rickets [37]. The role of cal-
cium in heart contractility was originally reported
in a publication in Nature by Bers [38] in which
the author discussed, for the first time the term
Cardiac excitation–contraction coupling, which
describes a process that enables the chambers of
the heart to contract and relax. Interestingly, this
study clearly established that of the ions involved
in regulating heart function, specifically the exci-
tation–contraction coupling process, calcium is
considered perhaps the most important. To
understand the basic physiology of heart function
requires, it is important to determine the exact cal-
cium level and the way by which it is moved
around the various organelles of the myocytes in
order to modulate the excitation–contraction cou-
pling process. Furthermore, spatial micro domains
within the cell are important in localizing the
molecular players that orchestrate cardiac func-
tion. Cardiomyopathy was also observed in pri-
mary hypoparathyroidism in older children and
in cases of thalassaemia due to hemosidrosis
[7,39]. The majority of these studies have indicated
that hypocalcemia is the sole/most important trig-
ger of cardiomyopathy in these patients. We
might postulate the possibility that the secondary
hyperparathyroidism observed in some of these
cases could have a protective role against cardio-
myopathy. In fact, the persistence of hypocalcemia
in cases with vitamin D deficiency as well as the
direct correlation between the onset of primary
hypoparathyroidism and cardiomyopathy devel-opment provided strong evidence in support of
this possibility. In addition, the complete recovery
of these patients without sequel in response to
calcium and vitamin D regiments provides an-
other strong proof in support of this idea.The role of vitamin D in cardiomyopathy
The cardiomyopathy observed in all these re-
ports was also associated with low 25-hydroxyvita-
min D and hence the role of vitamin deficiency as
a causative factor has to be considered. Pilz et al.
[40] discussed the impact of vitamin D on the
heart of an infant and concluded that vitamin D
deficiency is common among patients with myo-
cardial diseases because dietary intake and sun-
induced production of vitamin D are often insuffi-
cient. Knockout mice for the vitamin D receptor
develop myocardial hypertrophy and dysfunction.
It has also been shown that children with rickets
who suffered from severe heart failure could be
successfully treated with supplementation of vita-
min D plus calcium. In adults, almost all patients
with heart failure exhibit reduced 25-hydroxyvita-
min D levels, which are used to classify the vita-
min D status. In prospective studies, vitamin D
deficiency was an independent risk factor for mor-
tality, deaths due to heart failure and sudden car-
diac death. Several vitamin D effects on the
electrophysiology, contractility and structure of
the heart suggest that vitamin D deficiency might
be a causal factor for myocardial diseases. Based
on these observations, it can be concluded that
the obvious beneficial effects of vitamin D on
myocardial and overall health strongly argue for
the use of vitamin D supplementation to treat all
vitamin D-deficient patients with or at high risk
for myocardial diseases. Studies by Tishkof et al.
[41] have shown, using the Radioligand binding
assays (3)H-labeled 1,25(OH)(2)D(3), that a t-tu-
bule membrane fraction isolated from homoge-
nized rat ventricles contains a 1,25(OH)(2)D(3)-
binding activity similar to the classic vitamin D
receptors (VDR). This was the first study to dem-
onstrate that cardiac myocytes isolated from
VDR knockout mice present accelerated rates of
contraction and relaxation as compared to their
wild type counterparts and that 1,25(OH)(2)D(3)
directly reduced the contractility and the relaxa-
tion of the wild-type but not the knockout myo-
cytes. Moreover, they also observed that a VDR
is localized to t-tubules in the heart in a position
that allow it to exert an immediate effect on signal
transduction mediators and ion channels. The
authors of this study think that their novel
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standing 1,25(OH)(2)D(3) signal transduction in
heart cells and provides further evidence that
the VDR plays a role in heart structure and func-
tion. These observations make the requirement
of vitamin D supplementation in pregnant and
lactating mothers and their infants a more urgent
issue.
Studies of Weishaar et al. [42] have shown that
histological examination of ventricular muscle
from vitamin D3-deficient rats revealed a signifi-
cant decrease in myofibrillar area and a significant
increase in extracellular space. The increase in
extracellular space was accompanied by a signifi-
cant increase in myocardial collagen. However,
exposing these vitamin D3-deficient rats to a cal-
cium regiment failed to prevent/reverse this phe-
nomenon. Such alterations in the physical and
morphological properties of myocardial tissue
might represent the basis for the change in myo-
cardial contractile function that accompanies
lengthy periods of vitamin D3 deficiency. The
importance of vitamin D in heart function was fur-
ther confirmed in a study conducted by Judd et al.
[43]. They showed that vitamin D supplementa-
tion significantly decreased both blood pressure
levels and inflammatory responses as well as im-
proved insulin sensitivity resulting in a reduction
in cardiovascular disease complications and
death. Although a growing body of evidence sug-
gests that nutritional vitamin D supplementation
and potentially even treatment with synthetic
analogues of vitamin D may be cardio protective,
relatively few studies have examined either of
these compounds in a randomized, controlled
fashion. In a recent review Weber et al. [44] have
concluded that vitamin D levels play an important
role in maintaining myocardial viability and ECM
integrity in patients with cardiac hypertrophy and
fibrosis that accompanies vitamin D deficiency
and VDR ablation. On the contrary to the previous
findings Wang and De Luca [45] indicated that the
results from their investigations showed that the
vitamin D receptor was undetectable in skeletal,
cardiac, and smooth muscle, suggesting that the
function of vitamin D on muscle is either indirect
or did not involve the known receptor. The
numerous reports describing the systematic asso-
ciation between cardiomyopathy and vitamin D
deficiency in dark skinned infants, provides us
with strong indications that vitamin D plays a
key role in heart function, whether directly
through its effect on cell differentiation or indi-
rectly through its association with calcium defect
in cardiomyopathy. While the indirect role of vita-min D deficiency in this disease is widely ac-
cepted, more work is required to demonstrate its
direct implication in the onset of cardiomyopathy.
It will be particularly interesting to know why not
all cases of hypocalcemia and hypovitaminosis D
develop cardiomyopathy? It is plausible that
hypocalcemia and hypovitaminosis D act syner-
gistically in precipitating the cardiomyopathy,
and that is why not every case of rickets develop
cardiomyopathy.The role of parathormone (PTH) in
cardiomyopathy
Both high and low levels of PTH were observed
in cardiomyopathy as seen in hypocalcemia due to
hypovitaminosis D with secondary hyperparathy-
roidism and in cases of hypocalcaemia in primary
hypoparathyroidism, making the role of parathor-
mone per se in pathogenesis of cardiomyopathy
unlikely, yet it needs to be discussed.
In an extensive review by Wellenhiemer in 2004,
[46] the relation of PTH and cardiac diseases was
discussed. Primary hyperparathyroidism (pHPT),
caused by solitary parathyroid adenomas in 85%
of cases and diffuse hyperplasia in most of the
remaining cases, overproduces parathyroid hor-
mone (PTH), which mobilizes calcium to the blood
stream. A symptomatic phase of the disease has
been reported to be long and patients suffering
from symptomatic pHPT have increased mortal-
ity. Recently, studies have indicated an association
between pHPT and heart disease, and studies
in vitro have produced a number of theoretical ap-
proaches. An increased prevalence of cardiac
structural abnormalities such as left ventricular
hypertrophy (LVH), valvular and myocardial cal-
cification has been observed. Associations have
been found between PTH and LVH, and between
LVH and serum calcium. LV systolic function does
not seem to be affected in patients with pHPT,
whereas any influence on LV diastolic perfor-
mance needs further evaluation. The aim of this
review was to clarify the connection between
pHPT and cardiac disease. Although hyperpara-
thyroidism also leads to myocardial hypertrophy
and diastolic dysfunction through many mecha-
nisms, this extensive review did not provide con-
vincing evidence supporting this connection in
adult patients. Therefore, in our opinion it is diffi-
cult to make such a connection in the case of car-
diomyopathic infants with hypocalcemia and
secondary hyperparathyroidism. In fact, Well-
enhiemer did not provide convincing argument
and/or described strong evidence supporting a
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HYPOCALCEMIC RACHITIC CARDIOMYOPATHY IN INFANTSrole of hyperparathyroidism in the development
of cardiomyopathy in infants. An interesting find-
ing is that cardiomyopathy is seen in rickets in
which parathormone is high but it was not high
enough to normalize calcium. This supports that
an increase in PTH secretion per se does not play
a role in pathogenesis of cardiomyopathy.
It is difficult to pin point the role of parathormone
but further clinical observations have shown that
the combination of lower 25-OHD and higher
PTH concentrations appears to be associated inde-
pendently with sudden cardiac death (SCD) risk
among older adults without cardiovascular disease
[47]. However, further studies are needed to con-
firm these interesting observations.
The studies described above clearly indicate that
cardiomyopathy associated with rickets is caused
by hypocalcaemia in infants but when secondary
hyperparathyroidism develops, leading to nor-
malization of calcium, it may act as a protective
factor against cardiomyopathy. Further studies
are needed, and in our opinion echocardiography
examinations should become mandatory for all in-
fants with hypocalcaemia enabling the detection
of cardiomyopathy in an early phase. In the study
conducted by us (described above) on 35 infants
with rickets, we were unable to detect any abnor-
mal heart function by echocardiography study
and most of cases were from the age groups above
one year most of them obvious bow legs and hav-
ing normal serum calcium.The significance of early diagnosis
Rachitic hypocalcemic cardiomyopathy is a seri-
ous life threatening complication of infantile vita-
min D deficiency rickets which is a growing
community health problem, among breastfed in-
fants born to vitamin D deficient mothers; despite
protein calorie nutritional status being normal in
the majority of cases [48]. The cardiomyopathy
presenting with respiratory distress might be
missed as respiratory illness specially the clinical
features of rickets, namely bone deformities are
not apparent at this early age leading to late diag-
nosis and fatality with possible cardiogenic shock.
As described above, the excellent response to the
appropriate cardio-supportive treatment together
with calcium and vitamin D regiment highlights
the importance of the early diagnosis of cardiomy-
opathy in infants. In trying to pursue early diag-
nosis Uysal et al. [49] performed a study in
which they surveyed three groups of hypocalce-
mic patients. They found that echocardiography
examination revealed left ventricular dysfunction
in the pretreatment stage. The most striking findingwas the increase in the ratio of inter-ventricular
septal thickness to left ventricular posterior wall
thickness in 8 patients from group (III) and fewer
from other groups. The group 111 are cases with
severe biochemical findings [49]. From the
cardiomyopathy reviewed all of them had hypo-
calcemia without marked changes in their bone
structure. It seems that the persistence of hypocal-
cemia in these cases is what triggers the develop-
ment of cardiomyopathy, an observation that is
consistent with the of patients of group (111) de-
scribed by Uysals et al. [49]. We performed echo-
cardiography studies on 35 cases of frank rickets
from outpatient cases but none of them revealed
any abnormality suggestive of cardiomyopathy.
This might be explained by the fact that all of them
were classical cases of rickets and most of them
were having a normal calcium as seen in patients
presenting after one year of age [50]. We postulate
that the prolonged hypocalcemia during early age
could explain the rapid development of cardiomy-
opathy in infants. This conclusion is supported by
studies describing cases of primary hypoparathy-
roidism in older children [8] and many adults
[51–53] where the onset of cardiomyopathy is asso-
ciated with a long-standing hypocalcemia.Conclusion
Vitamin D deficiency is not a benign disease as it
might cause cardiomyopathy, hypocalcemic con-
vulsions, myelofibrosis, anemia, juvenile diabetes
mellitus, and many other complications. Plans for
prevention by antenatal supplementation of vita-
min D to pregnant mothers with 1000–2000 IU of
vitamin D3 is vital. All breastfed infants should be
given vitamin D supplementation of 400 units daily
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